Search
for
Sort by
Research 181–210 of 280
- A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia
- Abstract P1-12-19: A case report of successful hair preservation using scalp cooling with doxorubicin and cyclophosphamide during pregnancy
- APPROACHING ALOPECIA TREATMENT VIA POLYMERIC NANOPARTICLES: A BRIEF OVERVIEW
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
- Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- WNT Signaling in Disease
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Supportive Cryotherapy: A Review From Head to Toe
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Principles of chemotherapy
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Management of Dermatologic Toxicities
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma